Comments
Ranbaxy Laboratories Ltd has announced the following results for the quarter ended June 30, 2014: The Unaudited results for the Quarter ended June 30, 2014 The Company has posted a net profit of Rs. 7551.23 million for the quarter ended June 30, 2014 as compared to net (Loss) of Rs. (6088.09) million for the quarter ended June 30, 2013. Total Income has increased from Rs. 14699.29 million for the quarter ended June 30, 2013 to Rs. 22043.89 million for the quarter ended June 30, 2014. The Consolidated results for the Quarter ended June 30, 2014 The Group has posted a Net (Loss) after tax, minority interest and share in loss of associate of Rs (1859.28) million for the quarter ended June 30, 2014 as compared to Net (Loss) of Rs. (5242.44) million for the quarter ended June 30, 2013. Total Income has decreased from Rs 26695.80 million for the quarter ended June 30, 2012 to Rs 24517.07 million for the quarter ended June 30, 2014.
Source : BSE - >www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.